Package 45963-456-30

{"route": ["ORAL"], "spl_id": "daefa0d6-0d5a-48fe-897b-cbc3e1db47f7", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "upc": ["0345963454300"], "unii": ["V8G4MOF2V9"], "rxcui": ["597768", "597770", "597772"], "spl_set_id": ["ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (45963-456-30)", "package_ndc": "45963-456-30", "marketing_end_date": "20260930", "marketing_start_date": "20190322"}], "brand_name": "Deferasirox", "product_id": "45963-456_daefa0d6-0d5a-48fe-897b-cbc3e1db47f7", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "45963-456", "generic_name": "Deferasirox", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "500 mg/1"}], "application_number": "ANDA203560", "marketing_category": "ANDA", "marketing_end_date": "20260930", "marketing_start_date": "20190322"}